Boehringer Ingelheim is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. We are actively working to increase the accessibility and usability of our website and in doing so adhere to many of the available standards and guidelines. These guidelines explain how to make web content more accessible for people with disabilities. Conformance with these guidelines will help make the web more user friendly for all people. We are continually seeking out solutions that will bring all areas of the Site up to the same level of overall web accessibility.
Alternative and short descriptive texts are available for all multimedia and non-text content. A simplified version of the Site is also available, displaying a page with descriptive texts in the place of all images and videos. All videos and multimedia give a size indication, so that downloading time can be estimated. If software is required to view the videos, a plug in download link will be posted. An HTML substitute for Flash Player will also be provided for future videos. All videos will be presented with player software which enables the user to play, pause, stop forward and rewind the video. Live web casts will be archived after broadcasting to be available for a later viewing. No flashing content will be provided.
There is a strict separation of content and layout via the proper use of HTML and CSS (Cascading Style Sheet). Layout tables are avoided where possible. We are focusing on structuring items, making it possible to scan through a document and giving air to long texts.
This includes:
We try to offer a clear navigation structure that helps you to find the content you are looking for in an easy and quick way.
Links contain title attributes which describe content and make sense out of context.
The use of short sentences and paragraphs and multiple entry points to additional information sources e.g. via teaser elements and related content areas will make it easier to comprehend the content.
In the meantime, should you experience any difficulty in accessing the Boehringer Ingelheim website, please do not hesitate to contact us.
The Talk About Laminitis initiative continues to do sterling work in awareness-raising but also crucially in increasing the information we have about the disease and related conditions.
PPID (Cushing’s disease) is a significant risk factor for developing the devastating disease of laminitis, but thanks to this initiative, more cases can be identified early.
We encourage all horse owners, who are concerned about PPID in their horses, to take up this fantastic complimentary offer.
